Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
JL1, a specific epitope on CD43, is a potential biomarker for the diagnosis of acute leukemia. Although qualitative assays for detecting leukemia-specific CD43 exist, there is a need to develop quantitative assays for the same. Here, we developed two novel monoclonal antibodies (mAbs), 2C8 and 8E10, recognizing different epitopes on CD43. These clones are capable of pairing with YG5, another mAb against JL1 epitope, because they were selectively obtained using sandwich ELISA. Antigens recognized by 2C8 and 8E10 were confirmed as CD43 by western blotting using the CD43-hFC recombinant protein. When expression on various leukemic cell lines was investigated, 2C8 and 8E10 displayed a disparity in the distribution of the epitope. Enzyme assays revealed that these mAbs recognized a sialic acid-dependent epitope on CD43. Using normal thymus and lymph node paraffin-embedded tissues, we confirmed a difference in the epitopes recognized by the two mAbs that was predicted based on the maturity of the cells in the tissue. In summary, we developed and characterized two mAbs, 2C8 and 8E10, which can be used with YG5 in a sandwich ELISA for detecting leukemia-specific CD43.
Abstract
JL1, a specific epitope on CD43, is a potential biomarker for the diagnosis of acute leukemia. Although qualitative assays for detecting leukemia-specific CD43 exist, there is a need to develop quantitative assays for the same. Here, we developed two novel monoclonal antibodies (mAbs), 2C8 and 8E10, recognizing different epitopes on CD43. These clones are capable of pairing with YG5, another mAb against JL1 epitope, because they were selectively obtained using sandwich ELISA. Antigens recognized by 2C8 and 8E10 were confirmed as CD43 by western blotting using the CD43-hFC recombinant protein. When expression on various leukemic cell lines was investigated, 2C8 and 8E10 displayed a disparity in the distribution of the epitope. Enzyme assays revealed that these mAbs recognized a sialic acid-dependent epitope on CD43. Using normal thymus and lymph node paraffin-embedded tissues, we confirmed a difference in the epitopes recognized by the two mAbs that was predicted based on the maturity of the cells in the tissue. In summary, we developed and characterized two mAbs, 2C8 and 8E10, which can be used with YG5 in a sandwich ELISA for detecting leukemia-specific CD43.
참고문헌 (19)
- Remold-O'Donnell, E., "Leukocyte typing V: white cell differentiation antigens", pp.1697~1701 (1995), Oxford University Press
- Carlsson, S. R., "Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes", J. Biol. Chem, 251, pp.12779~12786 (1986)
- Shelley, C. S., "Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott- Aldrich syndrome. Proc", Natl. Acad. Sci. USA, 86, pp.2819~2823 (1989)
- Manjunath, N., "Negative regulation of T-cell adhesion and activation by CD43", Nature, 377, pp.535~539 (2002)
- Ardman, B, "CD43 interferes with T-lymphocyte adhesion", Proc. Natl. Acad. Sci. USA, 89, pp.5001~5005 (1992)
- Wooseok, S, "CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis", Blood, 114, pp.3567~3577 (2009)
- Rosenstein, Y., "CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1", Nature, 354, pp.233~235 (1991)
- Shin, Y. K, "Expresion of Leukemia-Associated Antigen, JL1, in Bone Marrow and Thymus", Am. J. Pathol, 158, pp.1473~1480 (2001)
- Park, C. S, "Diagnostic usefulness of monoclonal antibody for T lymphoblastic lymphoma", acute lymphoblastic leukemia-specific JL1 antigen in paraffin embedded tissue, 1999, pp.33, 1033~1038
- Sahin, U, "Serological identification of human tumor antigens", Curr. Opin. Immunol, 9, pp.709~716 (1997)
- Chung, J. K., "In vitro and in vivo properties of murine monoclonal antibody for a novel immature thymocyte-differentiated antigen, JL1", Nucl. Med. Biol, 24, pp.433~437 (1997)
- Park, W. S., "A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias", Leukemia, 12, pp.1583~1590 (1998)
- Jeon, Y. K., "Targeting of developmentally regulated epitope of CD43 for the treatment of acute leukemia", Cancer. Immunol. Immunother, 60, pp.1697~1706 (2011)
- Frizzera, G, "The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasma", Am. J. Clin. Pathol, 111, pp.S13~S39 (1999)
- Koníková, E., "Intracullular markers in acute myeloid leukemia diagnosis", Neoplasma, 45, pp.282~291 (1998)
- Ohashi, T., "A micro-ELISA system for the rapid and sensitive measurement of total and specific immunoglobulin E and clinical application to allergy diagnosis", Lab Chip, 9, pp.991~995 (2009)
- Cho, W. D., "Detection of Lung Adenocarcinoma Using CD66c Specific Sandwich ELISA", 석사, pp.2012
- Shin, M. H., "A novel monoclonal antibody 8F5 specific for CD66c of Lung Adenocarcinoma", 석사, pp.2009
- Scott, A. M., "Antibody-based immunological therapies", Curr. Opin. Immunol, 9, pp.717~722 (1997)